June 20 (Reuters) - The European Union's medicines
regulator on Friday granted a conditional authorisation for
Madrigal Pharmaceuticals' ( MDGL ) drug for a type of fatty
liver disease, paving the way to make it the first treatment
available for the condition in the region.
(Reporting by Sriparna Roy in Bengaluru; Editing by Shinjini
Ganguli)